177 related articles for article (PubMed ID: 22931442)
1. Synthesis and pharmacological evaluation of novel 4-alkyl-5-thien-2'-yl pyrazole carboxamides.
Lazzari P; Pau A; Tambaro S; Asproni B; Ruiu S; Pinna G; Mastinu A; Curzu MM; Reali R; Bottazzi ME; Pinna GA; Murineddu G
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):254-76. PubMed ID: 22931442
[TBL] [Abstract][Full Text] [Related]
2. Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide.
Murineddu G; Ruiu S; Loriga G; Manca I; Lazzari P; Reali R; Pani L; Toma L; Pinna GA
J Med Chem; 2005 Nov; 48(23):7351-62. PubMed ID: 16279795
[TBL] [Abstract][Full Text] [Related]
3. Novel pyrazole derivatives as neutral CB₁ antagonists with significant activity towards food intake.
Manca I; Mastinu A; Olimpieri F; Falzoi M; Sani M; Ruiu S; Loriga G; Volonterio A; Tambaro S; Bottazzi ME; Zanda M; Pinna GA; Lazzari P
Eur J Med Chem; 2013 Apr; 62():256-69. PubMed ID: 23357307
[TBL] [Abstract][Full Text] [Related]
4. Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood-brain-barrier.
Receveur JM; Murray A; Linget JM; Nørregaard PK; Cooper M; Bjurling E; Nielsen PA; Högberg T
Bioorg Med Chem Lett; 2010 Jan; 20(2):453-7. PubMed ID: 20015647
[TBL] [Abstract][Full Text] [Related]
5. PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats.
Horswill JG; Bali U; Shaaban S; Keily JF; Jeevaratnam P; Babbs AJ; Reynet C; Wong Kai In P
Br J Pharmacol; 2007 Nov; 152(5):805-14. PubMed ID: 17592509
[TBL] [Abstract][Full Text] [Related]
6. Chemical and biological investigation of cyclopropyl containing diaryl-pyrazole-3-carboxamides as novel and potent cannabinoid type 1 receptor antagonists.
Szabó G; Varga B; Páyer-Lengyel D; Szemzo A; Erdélyi P; Vukics K; Szikra J; Hegyi E; Vastag M; Kiss B; Laszy J; Gyertyán I; Fischer J
J Med Chem; 2009 Jul; 52(14):4329-37. PubMed ID: 19527048
[TBL] [Abstract][Full Text] [Related]
7. NESS038C6, a novel selective CB1 antagonist agent with anti-obesity activity and improved molecular profile.
Mastinu A; Pira M; Pani L; Pinna GA; Lazzari P
Behav Brain Res; 2012 Oct; 234(2):192-204. PubMed ID: 22771813
[TBL] [Abstract][Full Text] [Related]
8. Description of a bivalent cannabinoid ligand with hypophagic properties.
Fernández-Fernández C; Decara J; Bermúdez-Silva FJ; Sánchez E; Morales P; Gómez-Cañas M; Gómez-Ruíz M; Callado LF; Goya P; Rodríguez de Fonseca F; Martín MI; Fernández-Ruíz J; Meana JJ; Jagerovic N
Arch Pharm (Weinheim); 2013 Mar; 346(3):171-9. PubMed ID: 23371794
[TBL] [Abstract][Full Text] [Related]
9. Diaryl dihydropyrazole-3-carboxamides with significant in vivo antiobesity activity related to CB1 receptor antagonism: synthesis, biological evaluation, and molecular modeling in the homology model.
Srivastava BK; Joharapurkar A; Raval S; Patel JZ; Soni R; Raval P; Gite A; Goswami A; Sadhwani N; Gandhi N; Patel H; Mishra B; Solanki M; Pandey B; Jain MR; Patel PR
J Med Chem; 2007 Nov; 50(24):5951-66. PubMed ID: 17979261
[TBL] [Abstract][Full Text] [Related]
10. Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazole: a versatile architecture for CB2 selective ligands.
Pinna G; Loriga G; Lazzari P; Ruiu S; Falzoi M; Frau S; Pau A; Murineddu G; Asproni B; Pinna GA
Eur J Med Chem; 2014 Jul; 82():281-92. PubMed ID: 24922543
[TBL] [Abstract][Full Text] [Related]
11. Bioisosteric replacement of the pyrazole 3-carboxamide moiety of rimonabant. A novel series of oxadiazoles as CB1 cannabinoid receptor antagonists.
Chu CM; Hung MS; Hsieh MT; Kuo CW; Suja TD; Song JS; Chiu HH; Chao YS; Shia KS
Org Biomol Chem; 2008 Sep; 6(18):3399-407. PubMed ID: 18802648
[TBL] [Abstract][Full Text] [Related]
12. Rimonabant Sanofi-Synthélabo.
Fernandez JR; Allison DB
Curr Opin Investig Drugs; 2004 Apr; 5(4):430-5. PubMed ID: 15134285
[TBL] [Abstract][Full Text] [Related]
13. Pyrazole antagonists of the CB1 receptor with reduced brain penetration.
Fulp A; Zhang Y; Bortoff K; Seltzman H; Snyder R; Wiethe R; Amato G; Maitra R
Bioorg Med Chem; 2016 Mar; 24(5):1063-70. PubMed ID: 26827137
[TBL] [Abstract][Full Text] [Related]
14. Oxadiazole-diarylpyrazole 4-carboxamides as cannabinoid CB1 receptor ligands.
Lee SH; Seo HJ; Kim MJ; Kang SY; Song KS; Lee SH; Jung ME; Kim J; Lee J
Bioorg Med Chem Lett; 2009 Apr; 19(7):1899-902. PubMed ID: 19269817
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of milk ingestion and growth after administration of a neutral cannabinoid CB1 receptor antagonist on the first postnatal day in the mouse.
Fride E; Braun H; Matan H; Steinberg S; Reggio PH; Seltzman HH
Pediatr Res; 2007 Nov; 62(5):533-6. PubMed ID: 17805201
[TBL] [Abstract][Full Text] [Related]
16. Development of Oxygen-Bridged Pyrazole-Based Structures as Cannabinoid Receptor 1 Ligands.
Murineddu G; Asproni B; Corona P; Piras S; Lazzari P; Ruiu S; Legnani L; Toma L; Pinna GA
Molecules; 2019 Apr; 24(9):. PubMed ID: 31035548
[TBL] [Abstract][Full Text] [Related]
17. Structural analogs of pyrazole and sulfonamide cannabinoids: effects on acute food intake in mice.
Wiley JL; Marusich JA; Zhang Y; Fulp A; Maitra R; Thomas BF; Mahadevan A
Eur J Pharmacol; 2012 Nov; 695(1-3):62-70. PubMed ID: 22975289
[TBL] [Abstract][Full Text] [Related]
18. A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis.
Hsiao WC; Shia KS; Wang YT; Yeh YN; Chang CP; Lin Y; Chen PH; Wu CH; Chao YS; Hung MS
Diabetes Obes Metab; 2015 May; 17(5):495-504. PubMed ID: 25656402
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of new N-alkyl 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides as cannabinoid receptor ligands.
Silvestri R; Ligresti A; La Regina G; Piscitelli F; Gatti V; Lavecchia A; Brizzi A; Pasquini S; Allarà M; Fantini N; Carai MA; Bigogno C; Rozio MG; Sinisi R; Novellino E; Colombo G; Di Marzo V; Dondio G; Corelli F
Eur J Med Chem; 2010 Dec; 45(12):5878-86. PubMed ID: 20943290
[TBL] [Abstract][Full Text] [Related]
20. Structural-activity relationship study on C-4 carbon atom of the CB1 antagonist SR141716: synthesis and pharmacological evaluation of 1,2,4-triazole-3-carboxamides.
Jagerovic N; Hernandez-Folgado L; Alkorta I; Goya P; Martín MI; Dannert MT; Alsasua A; Frigola J; Cuberes MR; Dordal A; Holenz J
Eur J Med Chem; 2006 Jan; 41(1):114-20. PubMed ID: 16289480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
